Genetic test for predicting weight loss drug response
Part of Hormones & metabolism clinical trials.
This trial looks at whether your genes can predict how well you will respond to weight loss medications like semaglutide (Wegovy/Ozempic) or tirzepatide (Mounjaro). It may help doctors choose the right drug for you based on your DNA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your body mass index (BMI) is 40 or higher, or 37 or higher with a related health problem like diabetes or high blood pressure
- You are about to start taking semaglutide or tirzepatide for weight loss
- You have not had weight loss surgery before
- You do not have a history of certain cancers or pancreatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
This study looks at how a weight-loss medication affects people with obesity who may have a specific gene difference (caveolin-1). It aims to understand why some people respond differently to GLP-1 treatments like semaglutide.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study tests a simple cheek swab that may help doctors pick the most effective weight-loss medication for each person. Participation could help tailor your treatment, potentially improving results.
This study looks at how your genes affect your body's response to a diabetes medication called semaglutide. It may help people with slightly high blood sugar (pre-diabetes) understand why some respond better than others.
This study tests whether two weight-loss medications, semaglutide and tirzepatide, combined with an exercise program can help people with obesity lose weight. It may help you if you are looking for a structured medical approach to weight loss.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.